Mohammed Harris, PhD, MBA, MPH

Population Health Equity Leader. Longitudinal Multiomics and Exploratory Biomarkers Specialist. Leader, Board Member, Advisor, Investor. Public Health and Primary Care Diagnostics Champion.

📍 United States🔄 Updated September 2026💼 9 investments📅 3 years investing🗓 Last invested Jan 2026
VC🌍 United States
9
Total investments
3
Early stage
1
Mid stage
2
Late stage
3y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
2025
TimepointDx is engaged patient-centric blood sampling via novel capillary blood collection technologies for downstream translational discovery, exploratory biomarkers and diagnostics operations in pharmaceutical clinical trials and research. As pioneers of Longitudinal Capillary Multiomics™ (LCM™), TimepointDx enables robust longitudinal multiomics (genomics, transcriptomics, and proteomics) as standard of practice for clinical trials. LCM™ enables standardized and harmonized longitudinal capillary multiomics to create rich biomarker stories of clinical trial participants. TimepointDx is also pioneering novel technologies, including Aggregated Longitudinal Sequencing™ (ALseq™) for cost-effective WGS + WES and Capillary Stem Cell Reprogramming™ (CSCR™) for patient-specific iPSCs in vitro disease modeling. Learn more at www.timepointdx.com
Board Member
2025
~Advancing Healthcare by Increasing Vulnerable Populations Survival~ We develop medical innovations to address health issues and survival for underserviced and vulnerable populations around the world particularly infants in resource-limited settings. Our current initiative is the Dream Warmer to combat hypothermia in over 1 million babies a year. The first life-saving infant warmer that can be used by anyone, anywhere. This technology keeps babies warm for up to 6 hours without the need for electricity. Skin-to-Skin Complement Heat to supplement skin-to-skin (STS) or on its own Safe Temperature indicator clarifies safe start time Affordable Costs less and lasts longer than any other multi-use infant warmer on the market Intuitive Easy to prepare, use, and clean with minimal training. Low- literacy instructions provided Versatile Appropriate for delivery room, hospital, clinic, transport or home use Electricity-Free Water, boiled by any means, provides heat source Accessible For medical assessment or intervention Sanitary Easy-to-clean between uses with no attached fabric
Board Member
2025
💛 Supporting families. Advancing science. Driving hope. The TUBB2A Foundation is dedicated to improving the lives of children and families affected by TUBB2A-related neurodevelopmental conditions. We accelerate research, build global community, and advocate for early diagnosis and accessible care. Our focus: • Driving collaboration among scientists, clinicians, and families • Supporting translational research and clinical trials • Making complex science accessible to families and educators • Mapping and connecting affected families worldwide We believe every child deserves answers, support, and a hopeful path forward.
Board Member
2025
Myositis Support and Understanding (MSU) is a patient-led, all-volunteer 501(c)(3) nonprofit organization dedicated to improving the lives of and empowering those fighting myositis through education, support, awareness, advocacy, financial assistance, and access to research. MSU was founded by myositis patients for myositis patients and caregivers, initially as a small Facebook support group. Realizing the unmet needs in the myositis community, we took action, and in 2015 we officially became a nonprofit organization. We provide critical financial assistance for myositis patients including aid for mobility/assistive devices, medical bills, household expenses, and medical travel to see one of the few myositis experts. We collaborate with other myositis and rare disease organizations, pharmaceutical companies, and other unique partners to help promote treatment innovations and research with our collective eyes on a cure. Our focus will include patient-led research initiatives, like The Pain Project, and more on patient-reported outcome measures. We give myositis patients and caregivers a platform to use their voices! #MyositisLIFE, a program of MSU, is a community-based and interactive platform where contributing authors - no matter the level of writing experience - share stories, short videos, photos, and memes that show what life with myositis is like. While we are not defined by myositis, it does affect every aspect of our lives, making it difficult for family members and friends to understand some aspects. Visit MyositisLIFE.org Caring, empowering and educational support will always be a top priority at MSU. The Myositis Support Community, a partnership with Inspire, provides just that and a great way to connect. We also have a live video support program that brings myositis patients and caregivers from across the world closer together. Learn more about MSU and myositis on our comprehensive myositis website UnderstandingMyositis.
Investor/Advisor
2025
Biostate AIs mission is to develop generative AI that can benefit all of human health. We observe that biological beings are dynamic systems, with each individual slightly different today vs. yesterday or tomorrow. 🎁 Promotional RNAseq service for Academia: $10K Worth of RNAseq, Now Just $6K (or value of $10,000). Contact us: partnerships@biostate.ai
Investor/Advisor
2025
K-Dense is building the next generation of AI scientists to accelerate scientific research 100x.
Investor/Advisor
2023
Ecosense is a Silicon Valley based company providing and supporting a family of high accuracy, real-time radon detectors for professional home inspectors, radon mitigators, and general consumers. Our mission is to deliver a family of the world’s best radon detectors by leveraging ion chamber technology and user friendly data communications to become a part of your safer and smarter home.
Investor/Advisor
2023
Healthcare is converging to the home as more and more patients see doctors virtually, yet patients are constantly forced to go to a lab for a simple blood collection. This is because labs require plasma for 85% of the 2 billion blood draws done yearly in the US, but plasma can only be obtained from blood with specialized lab equipment. For patients who live too far away, or are too busy to go to a lab, we’ve built a device that with 3 simple steps enables them to self-collect and mail in their own plasma sample with the guarantee that it’s just as good as one collected in the lab.
Experience · 11 entries
All (11)
Investments (9)
Board (5)
2026
Board Member
2026
Mission: to promote awareness of Essential tremor disease, empower patients, and research its root causes to find a cure. DSF is not only made up of Doctors & Business Executives, but board members who are affected by Essential Tremor, along with DSF Founder Diann Shaddox. Diversity, Equity, and Anti-racism We commit to intentional action to be a fully inclusive, deliberately diverse, and anti-racist organization that respects and values the communities we serve. We will actively promote equity and social justice in neurology and the neurosciences. We will not stop until the world recognizes Essential Tremor and we have found new treatments & a cure. www.diannshaddoxfoundation.org
2025
Board Member
2025
TimepointDx is engaged patient-centric blood sampling via novel capillary blood collection technologies for downstream translational discovery, exploratory biomarkers and diagnostics operations in pharmaceutical clinical trials and research. As pioneers of Longitudinal Capillary Multiomics™ (LCM™), TimepointDx enables robust longitudinal multiomics (genomics, transcriptomics, and proteomics) as standard of practice for clinical trials. LCM™ enables standardized and harmonized longitudinal capillary multiomics to create rich biomarker stories of clinical trial participants. TimepointDx is also pioneering novel technologies, including Aggregated Longitudinal Sequencing™ (ALseq™) for cost-effective WGS + WES and Capillary Stem Cell Reprogramming™ (CSCR™) for patient-specific iPSCs in vitro disease modeling. Learn more at www.timepointdx.com
Board Member
2025
~Advancing Healthcare by Increasing Vulnerable Populations Survival~ We develop medical innovations to address health issues and survival for underserviced and vulnerable populations around the world particularly infants in resource-limited settings. Our current initiative is the Dream Warmer to combat hypothermia in over 1 million babies a year. The first life-saving infant warmer that can be used by anyone, anywhere. This technology keeps babies warm for up to 6 hours without the need for electricity. Skin-to-Skin Complement Heat to supplement skin-to-skin (STS) or on its own Safe Temperature indicator clarifies safe start time Affordable Costs less and lasts longer than any other multi-use infant warmer on the market Intuitive Easy to prepare, use, and clean with minimal training. Low- literacy instructions provided Versatile Appropriate for delivery room, hospital, clinic, transport or home use Electricity-Free Water, boiled by any means, provides heat source Accessible For medical assessment or intervention Sanitary Easy-to-clean between uses with no attached fabric
Board Member
2025
💛 Supporting families. Advancing science. Driving hope. The TUBB2A Foundation is dedicated to improving the lives of children and families affected by TUBB2A-related neurodevelopmental conditions. We accelerate research, build global community, and advocate for early diagnosis and accessible care. Our focus: • Driving collaboration among scientists, clinicians, and families • Supporting translational research and clinical trials • Making complex science accessible to families and educators • Mapping and connecting affected families worldwide We believe every child deserves answers, support, and a hopeful path forward.
Board Member
2025
Myositis Support and Understanding (MSU) is a patient-led, all-volunteer 501(c)(3) nonprofit organization dedicated to improving the lives of and empowering those fighting myositis through education, support, awareness, advocacy, financial assistance, and access to research. MSU was founded by myositis patients for myositis patients and caregivers, initially as a small Facebook support group. Realizing the unmet needs in the myositis community, we took action, and in 2015 we officially became a nonprofit organization. We provide critical financial assistance for myositis patients including aid for mobility/assistive devices, medical bills, household expenses, and medical travel to see one of the few myositis experts. We collaborate with other myositis and rare disease organizations, pharmaceutical companies, and other unique partners to help promote treatment innovations and research with our collective eyes on a cure. Our focus will include patient-led research initiatives, like The Pain Project, and more on patient-reported outcome measures. We give myositis patients and caregivers a platform to use their voices! #MyositisLIFE, a program of MSU, is a community-based and interactive platform where contributing authors - no matter the level of writing experience - share stories, short videos, photos, and memes that show what life with myositis is like. While we are not defined by myositis, it does affect every aspect of our lives, making it difficult for family members and friends to understand some aspects. Visit MyositisLIFE.org Caring, empowering and educational support will always be a top priority at MSU. The Myositis Support Community, a partnership with Inspire, provides just that and a great way to connect. We also have a live video support program that brings myositis patients and caregivers from across the world closer together. Learn more about MSU and myositis on our comprehensive myositis website UnderstandingMyositis.
Show all 11 entries ↓
Investment activity
2023–2026 · 9 investments
202322025620261
Recent (last 2 years)Earlier